Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner ...

The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company ...

Combining psychotherapy with low-dose ketamine is a relatively new approach to treating severe depression and post-traumatic ...

Ketamine clinics have been growing in popularity as an alternative depression treatment, but after the death of celebrity ...

Specialty pharmaceutical company PharmaTher Holdings’ drug application for Ketamine has received a June 4 approval goal date, advancing approval of the drug in the U.S. PharmaTher said it is ...

The Los Angeles medical examiner determined Matthew Perry's cause of death to be the acute effects of ketamine, more than a month after the death of the "Friends actor on Oct. 28. Perry had been found ...

Ministers said there were also growing concerns about THC vapes laced with ‘spice’, as well as synthetic opioids being sold ...

University life's celebrations can take a dangerous turn with the rise of ketamine use among young adults. This dissociative ...

When used for mental health treatment, a dose of ketamine — typically half a milligram per kilogram of body weight, less than ...